Service Online

Brief :On April 29, 2020, from 12:15 pm - 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2.

More information: Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19



On March 16, 2020, the FDA issued updated policy on COVID-19 Diagnostics: Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.

Stakeholder Call Details:

Registration is not necessary.

Date: April 29, 2020

Time: 12:15 p.m. – 1:15 p.m.
To ensure you are connected, please dial in 15 minutes prior to the start of the call.

U.S. Callers Dial:

International Callers Dial:

To view the slide presentation during the webinar:
https://www.mymeetings.com/nc/join.php?i=RWXW1175579&p=6110103&t=cExternal Link Disclaimer

Following the webinar, a transcript, recoding, and slides will be posted below.

Previous Town Halls from this Series